SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-006868
Filing Date
2024-09-06
Accepted
2024-09-06 17:43:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3255
  Complete submission text file 0001950047-24-006868.txt   4980
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36274 | Film No.: 241285390
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 26 NORTH EUCLID AVENUE PASADENA CA 91101
Business Address 26 NORTH EUCLID AVENUE PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

IRS No.: 954844319 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144